Japan Approves Pfizer’s Omicron XBB.1.5 Vaccine, Moderna’s Still under Review

The Japanese government on September 1 granted special approval for Pfizer/BioNTech’s updated monovalent COVID-19 vaccines adapted to the XBB.1.5 subvariant of Omicron. The new jabs are set for a rollout on September 20, targeting all generations. The government has already...read more